Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) FCF Margin (2024 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed FCF Margin for 2 consecutive years, with 26.34% as the latest value for Q4 2025.

  • For Q4 2025, FCF Margin rose 14231.0% year-over-year to 26.34%; the TTM value through Dec 2025 reached 65.8%, up 901.0%, while the annual FY2025 figure was 65.8%, 901.0% up from the prior year.
  • FCF Margin was 26.34% for Q4 2025 at Day One Biopharmaceuticals, down from 15.39% in the prior quarter.
  • The five-year high for FCF Margin was 111.99% in Q3 2024, with the low at 1271.11% in Q2 2024.